Evidence map›Paper›PMID 32766820›Full record

ReviewClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

Blastomycosis in Africa and the Middle East: A Comprehensive Review of Reported Cases and Reanalysis of Historical Isolates Based on Molecular Data.

Ilan S Schwartz, Jose F Muñoz, Chris R Kenyon, Nelesh P Govender, Lisa McTaggart, Tsidiso G Maphanga, Susan Richardson, Pierre Becker, Christina A Cuomo, Juan G McEwen and 1 more

Open access · bronzeAbstract readReview
In one paragraph

Review in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Perspectives on blastomycosis in Canada in the face of climate change.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2024
    Article
  13. Review
  14. Article
  15. Review
  16. Systemic Mycoses by Novel Onygenalean Fungal PathogensOpen forum infectious diseases · 2024
    Article
  17. Article
  18. The Geographic Distribution of Dimorphic Mycoses in the United States for the Modern Era.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  19. Blastomycosis: A Review of Mycological and Clinical Aspects.Journal of fungi (Basel, Switzerland) · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 5 countries.

Ilan S SchwartzDivision of Infectious Diseases, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.ORCID 0000-0002-7522-0281
Jose F MuñozBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Chris R KenyonClinical Sciences Unit, Institute of Tropical Medicine, Antwerp, Belgium.
Nelesh P GovenderNational Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa.ORCID 0000-0001-7869-9462
Lisa McTaggartPublic Health Ontario, Toronto, Ontario, Canada.
Tsidiso G MaphangaNational Institute for Communicable Diseases, a Division of the National Health Laboratory Service, Johannesburg, South Africa.
Susan RichardsonDivision of Microbiology, Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.
Pierre BeckerBelgian Coordinated Collections of Microorganisms (BCCM/IHEM) Fungal Collection, Mycology and Aerobiology, Sciensano, Brussels, Belgium.
Christina A CuomoBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
Juan G McEwenSchool of Medicine, Universidad de Antioquia, Medellín, Colombia.
Lynne SiglerAgricultural, Life and Environmental Sciences, University of Alberta, Edmonton, Alberta, Canada.
Broad Institute · USNational Health Laboratory Service · ZAUniversity of Alberta · CAHospital for Sick Children · CAInstituut voor Tropische Geneeskunde · BEPublic Health Ontario · CASciensano (Belgium) · BEUniversidad de Antioquia · CO

Funding

Fonds voor Wetenschappelijk Onderzoek-Vlaanderen, which fundedPublic Health Ontario, which funded
6 · The paper itself

Abstract

backgroundBlastomycosis has been reported from countries in Africa and the Middle East, but a decades-long debate has persisted regarding whether this is the same disease known in North America and caused by Blastomyces dermatitidis and Blastomyces gilchristii.

methodsWe reviewed published cases of human and veterinary blastomycosis from Africa and the Middle East. We abstracted epidemiological and clinical features of cases, including sites of disease, diagnosis, management, outcomes, and, where available, genetic and antigenic typing of case isolates. In addition, we sequenced nucleic acids from 9 clinical isolates from Africa deposited in global collections as B. dermatitidis; for 5, we sequenced the internal transcribed spacer regions, and for the other 4 we sequenced the whole genomes.

resultsWe identified 172 unique human patients with blastomycosis, including 159 patients from 25 African countries and 12 patients from 5 Middle Eastern countries, and also identified 7 reports of veterinary blastomycosis. In humans, cutaneous disease predominated (n = 100/137, 73%), followed by pulmonary (n = 73/129, 57%) and osteoarticular involvement (n = 61/128, 48%). Unusual direct microscopy/histopathological presentations included short hyphal fragments in tissues (n = 23/129, 18%). There were 34 genotyped case isolates that comprised 4 species: Blastomyces percursus (n = 22, 65%), from 8 countries throughout all regions; Blastomyces emzantsi (n = 9, 26%), from South Africa; B. dermatitidis (n = 1, 3%), from the Democratic Republic of Congo; and B. gilchristii (n = 2, 6%), from South Africa and Zimbabwe.

conclusionsBlastomycosis occurs throughout Africa and the Middle East and is caused predominantly by B. percursus and, at least in South Africa, B. emzantsi, resulting in distinct clinical and pathological patterns of disease.

Indexed as

BlastomycosisBlastomycesHumansMiddle EastSouth Africablastomycesdimorphic fungiemerging infectionsEndemic mycosisneglected tropical disease

Identifiers

PMID32766820
PMCPMC8492124
OpenAlexW3048074242

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.